Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMLX | ZTS | TAK | UTHR | NBIX |
| Company | Amylyx Pharmaceuticals Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.8700 | 150.97 | 13.15 | 236.83 | 139.37 |
| High | 1.9100 | 151.90 | 13.19 | 238.19 | 139.37 |
| Low | 1.8100 | 150.04 | 13.07 | 234.33 | 136.06 |
| Last | 1.8000 | 151.45 | 13.10 | 234.80 | 136.74 |
| Change | -0.0800 | +0.57 | -0.13 | -2.20 | -2.23 |
| % Change | -4.26% | +0.38% | -0.98% | -0.93% | -1.60% |
| Volume | 761,350 | 1,360,316 | 521,491 | 73,498 | 159,269 |
| 20-Day Average Volume | 2,200,263 | 4,022,228 | 1,695,441 | 512,321 | 762,136 |
| Previous Close | 1.8800 | 150.88 | 13.23 | 237.00 | 138.97 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.2900 | 157.79 | 13.43 | 234.22 | 136.49 |
| 20-Day Raw Stochastic | 0.00% | 24.35% | 0.57% | 61.12% | 41.22% |
| 20-Day Relative Strength | 23.48% | 34.87% | 34.13% | 51.10% | 49.79% |
| Weighted Alpha | -70.96 | -19.80 | -21.87 | +3.84 | +35.97 |
| Today's Opinion | 100% Sell | 88% Sell | 100% Sell | 80% Buy | 64% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 100% Sell | 80% Buy | 96% Buy |
| Last Month's Opinion | 100% Sell | 40% Sell | 56% Sell | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.08% since 04/18/24 | -1.24% since 04/18/24 | -0.57% since 04/18/24 | -0.81% since 04/18/24 | +2.81% since 04/18/24 |
| Low | 1.8200 on 04/25/24 | 144.80 on 04/22/24 | 13.08 on 04/25/24 | 233.27 on 04/24/24 | 130.13 on 04/19/24 |
| High | 2.0250 on 04/22/24 | 151.74 on 04/24/24 | 13.41 on 04/23/24 | 241.00 on 04/24/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | -32.84% since 03/25/24 | -9.89% since 03/25/24 | -7.53% since 03/25/24 | -3.79% since 03/25/24 | -2.84% since 03/25/24 |
| Low | 1.8200 on 04/25/24 | 144.80 on 04/22/24 | 13.08 on 04/25/24 | 221.53 on 04/01/24 | 130.13 on 04/19/24 |
| High | 2.9800 on 03/28/24 | 171.14 on 03/28/24 | 14.45 on 03/26/24 | 250.89 on 03/26/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | -88.16% since 01/25/24 | -19.27% since 01/25/24 | -10.56% since 01/25/24 | +7.15% since 01/25/24 | -3.37% since 01/25/24 |
| Low | 1.8200 on 04/25/24 | 144.80 on 04/22/24 | 13.08 on 04/25/24 | 208.62 on 02/08/24 | 128.00 on 02/07/24 |
| High | 19.9488 on 02/29/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 250.89 on 03/26/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | -88.70% since 10/25/23 | -7.61% since 10/25/23 | -9.76% since 10/25/23 | +4.68% since 10/25/23 | +25.90% since 10/25/23 |
| Low | 1.8200 on 04/25/24 | 144.80 on 04/22/24 | 13.08 on 04/25/24 | 208.62 on 02/08/24 | 103.63 on 11/10/23 |
| High | 19.9488 on 02/29/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 258.31 on 12/14/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 127,430 | 69,006,328 | 41,870,544 | 11,152,981 | 13,828,489 |
| Shares Outstanding, K | 67,782 | 457,359 | 3,164,818 | 47,059 | 99,507 |
| Annual Sales | 380,790,000 | 8,544,000,000 | 29,803,340,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | 49,270,000 | 2,344,000,000 | 2,345,930,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 108,450,000 | 2,213,000,000 | 7,556,070,000 | 614,700,000 | 515,200,000 |
| Last Quarter Net Income | 4,730,000 | 525,000,000 | 718,900,000 | 217,100,000 | 147,700,000 |
| 60-Month Beta | -0.93 | 0.85 | 0.53 | 0.52 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.07 on 02/22/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 4.36 on 02/21/24 | 1.44 on 02/07/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | 03/28/18 | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 2.79 | 28.11 | 6.86 | 11.82 | 57.89 |